{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:00:34Z","timestamp":1785128434344,"version":"3.55.0"},"reference-count":189,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic disorders, such as obesity, diabetes mellitus, metabolic dysfunction-associated steatotic liver disease, and atherosclerosis, collectively pose a severe global public health crisis. Systemic chronic low-grade inflammation caused by metabolic stress, namely metaflammation, is universally present in metabolic disorders. This pathological trait drives causal interactions and synergistic deterioration among distinct metabolic disorders, and cannot be efficiently alleviated by conventional clinical anti-inflammatory drugs. Efferocytosis refers to the programmed clearance of apoptotic cells mediated by phagocytes such as macrophages. It is indispensable for maintaining innate immune homeostasis, facilitating the resolution of metaflammation, and balancing metabolic microenvironments. This review comprehensively outlines the core characteristics and molecular mechanisms of efferocytosis, illustrates its regulatory networks in multiple metabolic disorders, concludes current therapeutic strategies targeting efferocytosis for metabolic disorders, and discusses the controversies and translational challenges of relevant interventions. This review systemically elucidates the shared core pathological mechanisms of defective efferocytosis underlying the interactive and progressive progression of multiple metabolic disorders, lays a theoretical foundation for the development of early diagnostic biomarkers and novel immune-targeted intervention strategies for metaflammation, and provides evidence-based rationale for translational research and clinical practice of related metabolic disorders.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1886016","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:25:43Z","timestamp":1785126343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efferocytosis: unifying pathogenic hub in metabolic disorders\u2014mechanistic landscapes, targeted therapies and translational bottlenecks"],"prefix":"10.3389","volume":"17","author":[{"given":"Dongze","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases","place":["Luzhou, Sichuan, China"]},{"name":"Metabolic Vascular Disease Key Laboratory of Sichuan Province","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Nephropathy","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases","place":["Luzhou, Sichuan, China"]},{"name":"Metabolic Vascular Disease Key Laboratory of Sichuan Province","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Nephropathy","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Burn and Plastic Surgery, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases","place":["Luzhou, Sichuan, China"]},{"name":"Metabolic Vascular Disease Key Laboratory of Sichuan Province","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Nephropathy","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[{"name":"Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases","place":["Luzhou, Sichuan, China"]},{"name":"Metabolic Vascular Disease Key Laboratory of Sichuan Province","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[{"name":"Metabolic Vascular Disease Key Laboratory of Sichuan Province","place":["Luzhou, Sichuan, China"]},{"name":"Chinese Academy of Sciences (CAS) Key Laboratory of Nutrition and Metabolism, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases","place":["Luzhou, Sichuan, China"]},{"name":"Metabolic Vascular Disease Key Laboratory of Sichuan Province","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Nephropathy","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases","place":["Luzhou, Sichuan, China"]},{"name":"Metabolic Vascular Disease Key Laboratory of Sichuan Province","place":["Luzhou, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Nephropathy","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01058-8","article-title":"Metabolic diseases in the East Asian populations","volume":"22","author":"Sun","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155999","article-title":"Global burden of metabolic diseases, 1990-2021","volume":"160","author":"Zhang","year":"2024","journal-title":"Metabolism"},{"key":"B3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5334\/gh.1451","article-title":"The weight of cardiovascular diseases: Addressing the global cardiovascular crisis associated with obesity","volume":"20","author":"Lopez-Jimenez","year":"2025","journal-title":"Glob Heart"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.346312.120","article-title":"Chronic tissue inflammation and metabolic disease","volume":"35","author":"Lee","year":"2021","journal-title":"Genes Dev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.10.004","article-title":"Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis","volume":"44","author":"Rodr\u00edguez-Morales","year":"2023","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1042\/bse0390105","article-title":"The final step in programmed cell death: phagocytes carry apoptotic cells to the grave","volume":"39","author":"deCathelineau","year":"2003","journal-title":"Essays Biochem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-111315-125315","article-title":"Cell removal: efferocytosis","volume":"33","author":"Henson","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0232-1","article-title":"The clearance of dead cells by efferocytosis","volume":"21","author":"Boada-Romero","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.839248","article-title":"Efferocytosis and its role in inflammatory disorders","volume":"10","author":"Ge","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.43268","article-title":"Efferocytosis and its role in rheumatic diseases","volume":"77","author":"Tang","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914871","article-title":"Efferocytosis and respiratory disease","volume":"24","author":"Zheng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.773344","article-title":"Efferocytosis in the central nervous system","volume":"9","author":"Zhao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12974-025-03428-0","article-title":"Microglia efferocytosis: an emerging mechanism for the resolution of neuroinflammation in Alzheimer's disease","volume":"22","author":"Chen","year":"2025","journal-title":"J Neuroinflammation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1641748","article-title":"Efferocytosis: a therapeutic strategy for diabetes and its vascular complications","volume":"13","author":"Song","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S418334","article-title":"Efferocytosis: an emerging therapeutic strategy for type 2 diabetes mellitus and diabetes complications","volume":"16","author":"Liu","year":"2023","journal-title":"J Inflamm Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2017.00086","article-title":"Mechanisms and consequences of defective efferocytosis in atherosclerosis","volume":"4","author":"Yurdagul","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01037-7","article-title":"Efferocytosis in atherosclerosis","volume":"21","author":"Adkar","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053010","article-title":"Apoptosis and clearance of apoptotic cells","volume":"36","author":"Nagata","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3780","article-title":"Macrophage efferocytosis in health and disease","volume":"41","author":"Razi","year":"2023","journal-title":"Cell Biochem Funct"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.01.010","article-title":"Chemotherapy triggers immune evasion by fostering LEPR+ Kupffer cell differentiation in liver metastases","volume":"44","author":"Wang","year":"2026","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"FASEB J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41590-019-0338-9","article-title":"Amateur phagocytes","volume":"20","author":"Visan","year":"2019","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41419-023-05931-9","article-title":"Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling","volume":"14","author":"Quarato","year":"2023","journal-title":"Cell Death Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1650465","article-title":"Efferocytosis-induced metabolic shift in bone macrophages drives lactate production and modulates inflammation and osteoclastogenesis","volume":"16","author":"Kannan","year":"2025","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-024-00878-y","article-title":"Efferocytosis and bone dynamics","volume":"22","author":"Batoon","year":"2024","journal-title":"Curr Osteoporos Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.08.001","article-title":"First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis","volume":"33","author":"Trzeciak","year":"2021","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/mmr.2021.12529","article-title":"Efferocytosis in multisystem diseases","volume":"25","author":"Zhang","year":"2022","journal-title":"Mol Med Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597528","article-title":"Multi-omics reveals efferocytosis-related hub genes as biomarkers for ustekinumab response in colitis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2021.02.025","article-title":"The ABCA1-efferocytosis axis: A new strategy to protect against atherosclerosis","volume":"518","author":"Chen","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108796","article-title":"G protein-coupled purinergic P2Y receptors in infectious diseases","volume":"267","author":"Carvalho","year":"2025","journal-title":"Pharmacol Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41419-022-05322-6","article-title":"Acinar ATP8b1\/LPC pathway promotes macrophage efferocytosis and clearance of inflammation during chronic pancreatitis development","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.023","article-title":"Bon EPOtit! S1P-mediated EPO signaling whets a macrophage's appetite for apoptotic cells","volume":"44","author":"Kolb","year":"2016","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00011-025-02075-8","article-title":"Impaired endothelial cell-derived CX3CL1-mediated macrophage efferocytosis in hypertrophic cardiomyopathy based on multi-omics analysis","volume":"74","author":"Zhang","year":"2025","journal-title":"Inflamm Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41467-025-67473-2","article-title":"Hyperglycemia exacerbates osteoarthritis by impairing macrophage efferocytosis through modulation of CD11b lactylation","volume":"16","author":"Zhou","year":"2025","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00152.2010","article-title":"HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin","volume":"299","author":"Friggeri","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-4624","article-title":"P2 purinergic receptors in tumor immunity","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601520","article-title":"Efferocytosis signaling in the regulation of macrophage inflammatory responses","volume":"198","author":"Elliott","year":"2017","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167130","article-title":"CX3CR1 deficiency promotes resolution of hepatic ischemia-reperfusion injury by regulating homeostatic function of liver infiltrating macrophages","volume":"1870","author":"Zhang","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.181800","article-title":"Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity","volume":"286","author":"Frasch","year":"2011","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biophys.093008.131234","article-title":"The distribution and function of phosphatidylserine in cellular membranes","volume":"39","author":"Leventis","year":"2010","journal-title":"Annu Rev Biophys"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01475-x","article-title":"CKLF1 disrupts microglial efferocytosis following acute ischemic stroke by binding to phosphatidylserine","volume":"32","author":"Fan","year":"2025","journal-title":"Cell Death Differ"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100411","article-title":"Flagging fusion: Phosphatidylserine signaling in cell-cell fusion","volume":"296","author":"Whitlock","year":"2021","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-9861(03)00083-3","article-title":"Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells--existence of a threshold","volume":"413","author":"Borisenko","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature06329","article-title":"BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO\/Dock180\/Rac module","volume":"450","author":"Park","year":"2007","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nature06307","article-title":"Identification of Tim4 as a phosphatidylserine receptor","volume":"450","author":"Miyanishi","year":"2007","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080387","article-title":"Stabilin receptors: Role as phosphatidylserine receptors","volume":"9","author":"Park","year":"2019","journal-title":"Biomolecules"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.202051","article-title":"Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation","volume":"30","author":"Yancey","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34487","article-title":"Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells","volume":"118","author":"Ichimura","year":"2008","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75417","article-title":"KIM-1-mediated phagocytosis reduces acute injury to the kidney","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.08.029","article-title":"LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system","volume":"184","author":"Gonias","year":"2014","journal-title":"Am J Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12376","article-title":"Apoptotic cell recognition receptors and scavenger receptors","volume":"269","author":"Penberthy","year":"2016","journal-title":"Immunol Rev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7508","DOI":"10.1038\/s41598-019-43535-6","article-title":"Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells","volume":"9","author":"Shirotani","year":"2019","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1038\/ncomms8386","article-title":"The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing","volume":"6","author":"Jun","year":"2015","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3876","article-title":"Expression of developmental endothelial locus-1 in a subset of macrophages for engulfment of apoptotic cells","volume":"172","author":"Hanayama","year":"2004","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2022.04.002","article-title":"MFG-E8 promotes tendon-bone healing by regulating macrophage efferocytosis and M2 polarization after anterior cruciate ligament reconstruction","volume":"34","author":"Geng","year":"2022","journal-title":"J Orthop Translat"},{"key":"B63","doi-asserted-by":"publisher","first-page":"14623","DOI":"10.1038\/s41598-017-15191-1","article-title":"Context-dependent compensation among phosphatidylserine-recognition receptors","volume":"7","author":"Penberthy","year":"2017","journal-title":"Sci Rep"},{"key":"B64","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41419-021-04168-8","article-title":"Exposure of a specific pleioform of multifunctional glyceraldehyde 3-phosphate dehydrogenase initiates CD14-dependent clearance of apoptotic cells","volume":"12","author":"Chaudhary","year":"2021","journal-title":"Cell Death Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152564","article-title":"Putting the brakes on phagocytosis: \"don't-eat-me\" signaling in physiology and disease","volume":"22","author":"Kelley","year":"2021","journal-title":"EMBO Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306388","article-title":"Biomimetic nano-degrader based CD47-SIRP\u03b1 immune checkpoint inhibition promotes macrophage efferocytosis for cardiac repair","volume":"11","author":"Gao","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200708043","article-title":"Inhibition of \"self\" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells","volume":"180","author":"Tsai","year":"2008","journal-title":"J Cell Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2008.12.001","article-title":"Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway","volume":"19","author":"Matozaki","year":"2009","journal-title":"Trends Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/science.1168988","article-title":"CD24 and Siglec-10 selectively repress tissue damage-induced immune responses","volume":"323","author":"Chen","year":"2009","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nature00811","article-title":"Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment","volume":"418","author":"Brown","year":"2002","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00018-025-05750-5","article-title":"CXCL12\/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1\/DOCK180\/RAC1 signaling in ANCA-associated glomerulonephritis","volume":"82","author":"Li","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-023-01942-y","article-title":"Single-cell RNA sequencing reveals RAC1 involvement in macrophages efferocytosis in diabetic kidney disease","volume":"47","author":"Song","year":"2024","journal-title":"Inflammation"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107692","article-title":"Macrophages use distinct actin regulators to switch engulfment strategies and ensure phagocytic plasticity in vivo","volume":"31","author":"Davidson","year":"2020","journal-title":"Cell Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.431","article-title":"Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis","volume":"7","author":"Yin","year":"2016","journal-title":"Cell Death Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2311548","article-title":"Enhancement of LC3-associated efferocytosis for the alleviation of intestinal inflammation","volume":"20","author":"Wu","year":"2024","journal-title":"Autophagy"},{"key":"B77","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41419-026-08431-8","article-title":"Modulation of immune cells and metabolic reprogramming in efferocytosis","volume":"17","author":"Oliveira","year":"2026","journal-title":"Cell Death Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1515\/mr-2025-0048","article-title":"Obesity: current developments in mechanisms, diagnosis, classification and the evolution of personalized management","volume":"6","author":"Shi","year":"2026","journal-title":"Med Rev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111315","article-title":"Adipose tissue and insulin resistance in obese","volume":"137","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213502","article-title":"Palmitate inhibits mouse macrophage efferocytosis by activating an mTORC1-regulated Rho kinase 1 pathway: therapeutic implications for the treatment of obesity","volume":"11","author":"S\u00f3s","year":"2022","journal-title":"Cells"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2025.100774","article-title":"Palmitic acid alters enhancers\/super-enhancers near inflammatory and efferocytosis-associated genes in human monocytes","volume":"66","author":"Tanwar","year":"2025","journal-title":"J Lipid Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.12.540252","article-title":"Diet-induced obesity dysregulates chromatin oxygen sensing regulating efferocytosis in macrophages","author":"Takahashi","year":"2023","journal-title":"bioRxiv"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.09.028","article-title":"Obesity impairs apoptotic cell clearance in asthma","volume":"131","author":"Fernandez-Boyanapalli","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.244","article-title":"Obesity impairs monocyte\/macrophage programming and efferocytosis in asthma","volume":"131","author":"Fernandez-Boyanapalli","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107719","article-title":"Metabolic and functional remodeling of colonic macrophages in response to high-fat diet-induced obesity","volume":"26","author":"Castoldi","year":"2023","journal-title":"iScience"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-024-3036-4","article-title":"Global risk factors, epidemiology, and disease burden of type 2 diabetes","author":"Chen","year":"2025","journal-title":"Sci China Life Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2023.2279533","article-title":"The vascular complications of diabetes: a review of their management, pathogenesis, and prevention","volume":"19","author":"Meir","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.2991","article-title":"TRB3 mediates advanced glycation end product-induced apoptosis of pancreatic \u03b2-cells through the protein kinase C \u03b2 pathway","volume":"40","author":"Wang","year":"2017","journal-title":"Int J Mol Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"9073037","DOI":"10.1155\/2016\/9073037","article-title":"Advanced glycation end products impair glucose-stimulated insulin secretion of a pancreatic \u03b2-cell line INS-1-3 by disturbance of microtubule cytoskeleton via p38\/MAPK activation","volume":"2016","author":"You","year":"2016","journal-title":"J Diabetes Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100695","article-title":"Advanced glycation end products (AGEs) inhibit macrophage efferocytosis of apoptotic \u03b2 cells through binding to the receptor for AGEs","volume":"208","author":"Mao","year":"2022","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004565","article-title":"Apoptotic \u03b2-cells induce macrophage reprogramming under diabetic conditions","volume":"293","author":"Ward","year":"2018","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/414792a","article-title":"Beta-cell death during progression to diabetes","volume":"414","author":"Mathis","year":"2001","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.10578","article-title":"Diabetic foot ulcers: a review","volume":"330","author":"Armstrong","year":"2023","journal-title":"JAMA"},{"key":"B96","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12964-025-02092-4","article-title":"The efferocytosis dilemma: how neutrophil extracellular traps and PI3K\/Rac1 complicate diabetic wound healing","volume":"23","author":"Xie","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502270","article-title":"Correction of MFG-E8 resolves inflammation and promotes cutaneous wound healing in diabetes","volume":"196","author":"Das","year":"2016","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2025.02.030","article-title":"Methylglyoxal deteriorates macrophage efferocytosis in diabetic wounds through ROS-induced ubiquitination degradation of KLF4","volume":"231","author":"Zhu","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.016","article-title":"ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis","volume":"79","author":"He","year":"2023","journal-title":"J Hepatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1424218","article-title":"The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities","volume":"14","author":"Ahmadizad Firouzjaei","year":"2024","journal-title":"Front Oncol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1521554","article-title":"Unveiling macrophage dynamics and efferocytosis-related targets in diabetic kidney disease: insights from single-cell and bulk RNA-sequencing","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2024.200338","article-title":"Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies","volume":"23","author":"Rizza","year":"2024","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/srep36207","article-title":"MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes","volume":"6","author":"Babu","year":"2016","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101414","article-title":"Inflammation in MASLD progression and cancer","volume":"7","author":"Kim","year":"2025","journal-title":"JHEP Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.119053","article-title":"Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"400","author":"Iturbe-Rey","year":"2025","journal-title":"Atherosclerosis"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100960","article-title":"Efferocytosis in liver disease","volume":"6","author":"Shi","year":"2023","journal-title":"JHEP Rep"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj3289","article-title":"Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis","volume":"10","author":"Wang","year":"2024","journal-title":"Sci Adv"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030341","article-title":"TREM2 regulates the removal of apoptotic cells and inflammatory processes during the progression of NAFLD","volume":"12","author":"Liebold","year":"2023","journal-title":"Cells"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2025.04.009","article-title":"TREM2-expressing macrophages in liver diseases","volume":"37","author":"Wang","year":"2026","journal-title":"Trends Endocrinol Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.11.013","article-title":"Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis","volume":"31","author":"Cai","year":"2020","journal-title":"Cell Metab"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.10.016","article-title":"MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease","volume":"64","author":"Petta","year":"2016","journal-title":"J Hepatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"106641","DOI":"10.1016\/j.ejim.2025.106641","article-title":"Integrating sTREM2 into non-invasive pathways for early MASH in MASLD","volume":"147","author":"Lv","year":"2026","journal-title":"Eur J Intern Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"106418","DOI":"10.1016\/j.ejim.2025.07.014","article-title":"sTREM2 evaluation in women with metabolic dysfunction-associated steatotic liver disease: advancing diagnostic approaches for early MASH","volume":"141","author":"Mahmoudian","year":"2025","journal-title":"Eur J Intern Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00914-y","article-title":"Atherosclerosis and multi-organ-associated pathologies","volume":"44","author":"Keeter","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1273596","article-title":"Role of vascular smooth muscle cell clonality in atherosclerosis","volume":"10","author":"Luo","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90520","article-title":"MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis","volume":"127","author":"Cai","year":"2017","journal-title":"J Clin Invest"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-022-00023-x","article-title":"The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis","volume":"1","author":"Jarr","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101178","article-title":"CD47-SIRP\u03b1 signaling-inspired engineered monocytes for preventing the progression of atherosclerotic plaques","volume":"28","author":"Xia","year":"2024","journal-title":"Mater Today Bio"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.5.1396","article-title":"Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine","volume":"92","author":"Sambrano","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209634200","article-title":"Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4\/MD-2, and inhibits phagocytosis of apoptotic cells","volume":"278","author":"Miller","year":"2003","journal-title":"J Biol Chem"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319320005","article-title":"Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases","volume":"19","author":"Fiorentino","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae102","article-title":"miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling","volume":"120","author":"Rawal","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2020.5647","article-title":"Unexpected role of nonimmune cells: amateur phagocytes","volume":"40","author":"Sihombing","year":"2021","journal-title":"DNA Cell Biol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048378","article-title":"Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human","volume":"142","author":"Pan","year":"2020","journal-title":"Circulation"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2006348117","article-title":"Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade","volume":"117","author":"Wang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-026187","article-title":"Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses","volume":"109","author":"Kirsch","year":"2007","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.779","article-title":"Progranulin deficiency suppresses allergic asthma and enhances efferocytosis via PPAR-\u03b3\/MFG-E8 regulation in macrophages","volume":"11","author":"Huang","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.10.005","article-title":"The deficiency of macrophage erythropoietin signaling contributes to delayed acute inflammation resolution in diet-induced obese mice","volume":"1865","author":"Luo","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-022-00038-4","article-title":"Statins boost the macrophage eat-me signal to keep atherosclerosis at bay","volume":"1","author":"Eberhardt","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41569-022-00699-5","article-title":"Statins promote efferocytosis in atherosclerotic plaques","volume":"19","author":"Fern\u00e1ndez-Ruiz","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108282","article-title":"Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions","volume":"238","author":"Tajbakhsh","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2024.2311875","article-title":"Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system","volume":"17","author":"Xiao","year":"2024","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.02.029","article-title":"Myotoxicity of statins: mechanism of action","volume":"175","author":"du Souich","year":"2017","journal-title":"Pharmacol Ther"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2019.09.007","article-title":"Drug-induced liver injury from statins","volume":"24","author":"Meurer","year":"2020","journal-title":"Clin Liver Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2024.0579","article-title":"4-Octyl itaconate promotes diabetic wound healing by enhancing pro-resolving macrophages via the efferocytosis-MCT1-lactate-GPR132 pathway and macrophage-independent synergistic effects","volume":"50","author":"Tu","year":"2025","journal-title":"Diabetes Metab J"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i9.696","article-title":"Evolving spectrum of diabetic wound: mechanistic insights and therapeutic targets","volume":"13","author":"Chakraborty","year":"2022","journal-title":"World J Diabetes"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.2478\/sjecr-2018-0077","article-title":"Biological mechanisms of chronic wound and diabetic foot healing: the role of collagen","volume":"19","author":"Stupin","year":"2018","journal-title":"Ser J Exp Clin Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-42544-6","article-title":"The network pharmacology prediction and experiment validation of Astragalus membranaceus for alleviating silicosis fibrosis via decreasing MMP9 and EGFR expression","volume":"16","author":"Yang","year":"2026","journal-title":"Sci Rep"},{"key":"B145","doi-asserted-by":"publisher","first-page":"9340637","DOI":"10.1155\/2016\/9340637","article-title":"Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes","volume":"2016","author":"Chen","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1538867","article-title":"Therapeutic potential of five frequently prescribed herbs in obesity-associated Hashimoto's thyroiditis: insights from efferocytosis regulation","volume":"12","author":"Zhou","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114243","article-title":"Sulforaphane promotes diabetic wound healing by regulating macrophage efferocytosis and polarization","volume":"150","author":"Huang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117578","article-title":"Isoliquiritigenin alleviates SLC7A11-mediated efferocytosis inhibition to promote wounds healing in diabetes","volume":"180","author":"Gong","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1521069113","article-title":"Cd47-Sirp\u03b1 interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells","volume":"113","author":"Bian","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2029834","article-title":"Effect of CD47 blockade on vascular inflammation","volume":"384","author":"Jarr","year":"2021","journal-title":"N Engl J Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.11.048","article-title":"Immune checkpoint therapies and atherosclerosis: mechanisms and clinical implications: JACC state-of-the-art review","volume":"79","author":"Vuong","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.122.317049","article-title":"2021 Jeffrey M. Hoeg Award Lecture: defining the role of efferocytosis in cardiovascular disease: a focus on the CD47 (Cluster of Differentiation 47) axis","volume":"42","author":"Jarr","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.07.005","article-title":"CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B158","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12951-024-02463-y","article-title":"Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE-\/- mice","volume":"22","author":"Qiu","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152400","article-title":"Engineered bifunctional extracellular vesicles simultaneously promoting senolysis and efferocytosis for anti-aging therapy in diabetic mice","volume":"778","author":"Qu","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00253","article-title":"Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry","volume":"9","author":"Rodr\u00edguez-Fern\u00e1ndez","year":"2018","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127057","article-title":"Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes","volume":"10","author":"Pujol-Autonell","year":"2015","journal-title":"PLoS One"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.70034","article-title":"Sex and gender dimensions in hazard and risk assessment of engineered nanomaterials","volume":"17","author":"Bo\u017eicevic","year":"2025","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2017.09.002","article-title":"Progress towards standardized and validated characterizations for measuring physicochemical properties of manufactured nanomaterials relevant to nano health and safety risks","volume":"9","author":"Gao","year":"2018","journal-title":"NanoImpact"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.199570","article-title":"Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob\/ob mice and reversal by a fish oil diet","volume":"105","author":"Li","year":"2009","journal-title":"Circ Res"},{"key":"B165","article-title":"Aerobic exercise improves ventricular remodeling by promoting macrophages to phagocytose dying cardiomyocytes in heart failure model","volume-title":"Research Square","author":"Liu","year":"2024"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1080\/21623945.2020.1823140","article-title":"Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK\/HO-1- pathway","volume":"9","author":"Kwon","year":"2020","journal-title":"Adipocyte"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2026.119092","article-title":"Intrinsic neutrophil dysregulation in programmed cell death promotes neutrophilic inflammation in cystic fibrosis","volume":"196","author":"Hu","year":"2026","journal-title":"Biomed Pharmacother"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.7555\/JBR.38.20240375","article-title":"Remote neuromuscular electrical stimulation upregulates MDK to enhance macrophage efferocytosis via LRP1 in wound healing","volume":"40","author":"Zong","year":"2026","journal-title":"J Biomed Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12943-025-02484-7","article-title":"Efferocytosis: the art of cellular clearance and novel perspectives in disease therapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol Cancer"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.02.017","article-title":"Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33","volume":"43","author":"Lamorte","year":"2025","journal-title":"Cancer Cell"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1074","article-title":"Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors","volume":"17","author":"Gerber","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-0521-5","article-title":"TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy","volume":"18","author":"Dayoub","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.32604\/or.2023.042383","article-title":"Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy","volume":"32","author":"Chen","year":"2023","journal-title":"Oncol Res"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15033","article-title":"Monoclonal anti-CD47 interference in red cell and platelet testing","volume":"59","author":"Velliquette","year":"2019","journal-title":"Transfusion"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1378647","article-title":"Targeting the CD47\/SIRP\u03b1 pathway in malignancies: recent progress, difficulties and future perspectives","volume":"14","author":"Jiang","year":"2024","journal-title":"Front Oncol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front Pharmacol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114356","article-title":"The effects of protein corona on in vivo fate of nanocarriers","volume":"186","author":"Xiao","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"B180","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12964-024-01994-z","article-title":"Staphylococcus aureus vesicles impair cutaneous wound healing through p38 MAPK-MerTK cleavage-mediated inhibition of macrophage efferocytosis","volume":"23","author":"Ou","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2024.10.003","article-title":"Electroacupuncture improves cardiac function in hyperlipidemic rats by enhancing efferocytosis in myocardial macrophages via the PPAR\u03b3-LXR\u03b1-MerTK pathway","volume":"15","author":"Han","year":"2024","journal-title":"J Tradit Complement Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i5.101473","article-title":"Impaired efferocytosis by monocytes and monocyte-derived macrophages in patients with poorly controlled type 2 diabetes","volume":"16","author":"Mao","year":"2025","journal-title":"World J Diabetes"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.7150\/thno.123651","article-title":"Myeloid cell-specific \u03b22-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1","volume":"16","author":"Nayak","year":"2026","journal-title":"Theranostics"},{"key":"B184","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41419-023-05594-6","article-title":"Caspase-9 driven murine model of selective cell apoptosis and efferocytosis","volume":"14","author":"Batoon","year":"2023","journal-title":"Cell Death Dis"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.4c09164","article-title":"A disintegrin and metalloproteinase 17 disrupts bovine macrophage MER proto-oncogene tyrosine kinase integrity to impede apoptotic cell clearance and promote inflammation in clinical mastitis","volume":"73","author":"Wang","year":"2025","journal-title":"J Agric Food Chem"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1332482","article-title":"The role of secreted proteins in efferocytosis","volume":"11","author":"Hou","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/1424404","article-title":"The important role of phosphatidylserine, ADAM17, TNF-alpha, and soluble MER on efferocytosis activity in central obesity","volume":"2024","author":"Purnama","year":"2024","journal-title":"J Obes"},{"key":"B188","doi-asserted-by":"publisher","first-page":"106796","DOI":"10.1016\/j.ejim.2026.106796","article-title":"sTREM2 as an early MASH biomarker: a commentary on generalizability and mechanistic interpretation","author":"Peng","year":"2026","journal-title":"Eur J Intern Med"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1460431","article-title":"Identification and validation of efferocytosis-related biomarkers for the diagnosis of metabolic dysfunction-associated steatohepatitis based on bioinformatics analysis and machine learning","volume":"15","author":"Cao","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1886016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:25:45Z","timestamp":1785126345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1886016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":189,"alternative-id":["10.3389\/fimmu.2026.1886016"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1886016","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"1886016"}}